Cancel
About Philip Tagari
Philip Tagari is the Chief Scientific Officer at insitro, known for his expertise as a drug hunter and his transition from Amgen's discovery lab to leveraging machine learning tools in drug discovery.
Known information
Philip Tagari serves as the Chief Scientific Officer at insitro, where he applies his extensive experience in drug discovery and development. Previously, he worked at Amgen’s discovery lab, focusing on innovative approaches to identifying new drug candidates. Tagari is recognized in the pharmaceutical industry as a leading scientist and an adept drug hunter. His recent move to insitro marks a significant shift in his career, embracing machine learning tools to enhance the drug discovery process. His expertise and innovative approach in utilizing advanced technologies demonstrate his pivotal role in the field.
About insitro
Insitro is a biotechnology company that leverages machine learning and large-scale data analysis to expedite drug discovery and development, focusing on metabolism, oncology, and neuroscience.
Report inaccurate information
